title: Peanut allergenicity.
abstract: OBJECTIVE
  To provide the reader with a relevant review of the structure and allergenicity of the major peanut allergens, while also exploring predictors of clinical reactivity to peanuts, the natural history of peanut allergy, and novel therapeutic strategies for peanut hypersensitivity.
  
  
  METHODS
  A PubMed search for the years 1980 to 2004 was performed using the following search terms: peanut allergy, food allergy, anaphylaxis, peanut allergen structure, and peanut immunotherapy.
  
  
  METHODS
  Articles highlighting major advances in the study of peanut allergy were selected for further review.
  
  
  RESULTS
  Peanut allergy is the most serious of the hypersensitivity reactions to foods due to its persistence and high risk of severe anaphylaxis. The major peanut allergens and their associated immunodominant IgE-binding epitopes have been characterized. Definition of these allergens has lead to an increased understanding of the peanut-specific immunologic response and improved predictors of clinical reactivity to peanuts. An understanding of these mechanisms is vital for the eventual development of safe and effective immunotherapy for peanut allergic patients. Novel therapeutic and diagnostic approaches are being developed for patients with peanut hypersensitivity.
  
  
  CONCLUSIONS
  Improved understanding of the molecular structure of the major peanut allergens and the peanut-specific immune response has lead to significant diagnostic and therapeutic advances in the study of peanut allergy.
authors.affiliation: Division of Pediatric Allergy and Immunology, Duke University Medical Center, Durham, North Carolina 27710, USA.
authors.forename: Amy M
authors.initials: AM
authors.lastname: Scurlock
authors.forename: A Wesley
authors.initials: AW
authors.lastname: Burks
mesh_terms: D000485:Allergens / Q000276:immunology; D010367:Arachis / Q000276:immunology*; D005511:Food Handling; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D021183:Peanut Hypersensitivity / Q000209:etiology* / Q000628:therapy; D012307:Risk Factors
chemical_list: D000485:Allergens; D007073:Immunoglobulin E